.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Dow
Covington
US Department of Justice
Healthtrust
Fuji
Cerilliant
Accenture
McKinsey
Moodys

Generated: December 14, 2017

DrugPatentWatch Database Preview

Trimethoprim hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for trimethoprim hydrochloride and what is the scope of trimethoprim hydrochloride patent protection?

Trimethoprim hydrochloride
is the generic ingredient in one branded drug marketed by Allegis and Aytu Pharms, and is included in two NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Trimethoprim hydrochloride has thirteen patent family members in eleven countries.

There are thirty-three drug master file entries for trimethoprim hydrochloride. Four suppliers are listed for this compound.
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Aytu PharmsPRIMSOLtrimethoprim hydrochlorideSOLUTION;ORAL074374-001Jun 23, 1995DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
AllegisPRIMSOLtrimethoprim hydrochlorideSOLUTION;ORAL074973-001Jan 24, 2000RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
AllegisPRIMSOLtrimethoprim hydrochlorideSOLUTION;ORAL074973-001Jan 24, 2000RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: trimethoprim hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
AllegisPRIMSOLtrimethoprim hydrochlorideSOLUTION;ORAL074973-001Jan 24, 2000► Subscribe► Subscribe
AllegisPRIMSOLtrimethoprim hydrochlorideSOLUTION;ORAL074973-001Jan 24, 2000► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: trimethoprim hydrochloride

Country Document Number Estimated Expiration
Canada2260852► Subscribe
World Intellectual Property Organization (WIPO)9805312► Subscribe
Japan3778518► Subscribe
Japan2000505093► Subscribe
Austria236624► Subscribe
Spain2196355► Subscribe
European Patent Office0938302► Subscribe
Australia727175► Subscribe
Denmark0938302► Subscribe
Portugal938302► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Dow
Citi
Johnson and Johnson
Moodys
UBS
McKesson
Covington
Cantor Fitzgerald
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot